KKR Buys Medicover India Hospital Business in €1.2-Billion Healthcare Deal

Global investment firm KKR has agreed to acquire Medicover’s hospital business in India for €1.2 billion, marking one of the latest major investments in the country’s rapidly expanding private healthcare sector.

Swedish healthcare and diagnostics company Medicover announced the transaction on 6 August, saying the sale would allow it to focus more closely on its core markets in Poland, Germany and Romania. KKR will acquire the Indian hospital operations through investment funds managed by the firm. The transaction is expected to be completed in the fourth quarter of 2026, subject to the required conditions and approvals.

The deal values Medicover’s Indian hospital business at a significant level and highlights the growing interest of global investors in India’s healthcare market. Medicover owns 66.1% of Medicover Hospitals India, while minority shareholders hold the remaining 33.9%. The Indian business generated revenue of €220.5 million during the 12 months ended 30 June 2026. India accounted for around 10% of Medicover’s total revenue in the second quarter.

For Medicover, the transaction is primarily a strategic move. The company said the divestment would provide gross cash proceeds of €740 million while allowing it to concentrate its operational and strategic resources on its European markets.

For KKR, however, the deal deepens its exposure to India’s hospital industry. The investment comes at a time when private healthcare providers are expanding their networks to meet growing demand for specialised medical treatment.

India’s healthcare sector has attracted increasing interest from private equity firms in recent years. Rising incomes, greater health insurance coverage, an ageing population and growing demand for specialised treatment have made hospitals an attractive area for long-term investment.

The Indian hospital market also remains fragmented, creating opportunities for large healthcare groups and financial investors to expand through acquisitions. Investment can support the development of new facilities, expansion of existing hospitals, advanced medical equipment and specialised treatment centres.

For patients, the impact of the transaction will depend on what KKR does with the business after the acquisition. Fresh investment could support hospital expansion, modern equipment, digital healthcare services and improved clinical infrastructure. However, investment alone does not automatically translate into more affordable treatment. Staffing, pricing, quality of care and access will remain important measures of the deal’s success.

The transaction also reflects the growing importance of private healthcare infrastructure in India. As demand for complex treatments increases, hospitals require substantial capital for intensive care units, operating theatres, diagnostic facilities, cancer care, cardiac services and other specialised departments.

Medicover’s decision to sell its Indian operations also illustrates how international healthcare companies are reassessing their geographic priorities. The company intends to focus on Poland, Germany and Romania, while KKR takes on ownership of its Indian hospital business.

The deal could lead to further consolidation in India’s hospital sector as investors look for established networks that can be expanded across major cities and regional healthcare markets.

The next stage will be watched closely by the healthcare industry. Once completed, KKR’s acquisition could bring fresh capital and a new growth strategy to Medicover’s Indian hospital operations.

For India, the deal is another sign that healthcare is increasingly being viewed not only as a social necessity but also as a major investment sector. The challenge will be ensuring that expanding private capital also translates into better capacity, quality treatment and wider access for patients.